Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
siG12D-LODER in Locally Advanced Pancreatic Cancer
NCT01676259Phase 2Unknown
- Sponsor
- Silenseed
- Start
- Mar 2018
- Primary completion
- Oct 2022
- Modality
- Device-based Delivery, Conjugated siRNA, Chemically Modified siRNA
- Countries
- 2
01
Overview
A Phase 2 trial of siG12D-LODER in pancreatic ductal adenocarcinoma (PDAC), sponsored by Silenseed. Status: unknown.
02
Drugs
siG12D-LODER
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01676259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01676259.